ArticleJournal for immunotherapy of cancer2021

Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma.

Haibo Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.